<DOC>
	<DOCNO>NCT00453232</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy , bleomycin , etoposide , cisplatin , work different way stop growth tumor cell , either kill cell stop divide . Colony-stimulating factor , pegfilgrastim , may increase number immune cell find bone marrow peripheral blood may help immune system recover side effect chemotherapy . Giving combination chemotherapy together pegfilgrastim may kill tumor cell . PURPOSE : This phase II trial study side effect well give combination chemotherapy together pegfilgrastim work treat men metastatic germ cell tumor .</brief_summary>
	<brief_title>Combination Chemotherapy Pegfilgrastim Treating Men With Metastatic Germ Cell Tumors</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine feasibility accelerate treatment comprise bleomycin , etoposide , cisplatin , pegfilgrastim men metastatic germ cell tumor . - Determine toxicity regimen ( particularly respect renal , pulmonary , neurological function ) patient . Secondary - Determine response rate patient treat regimen . - Determine progression-free survival patient treat regimen . OUTLINE : This non-randomized , pilot study . Patients receive etoposide IV day 1-3 , cisplatin IV day 1 2 , bleomycin IV 2 hour day 2 , 6 , 10 . Patients also receive pegfilgrastim subcutaneously day 4 . Treatment repeat every 14 day 4 course absence disease progression unacceptable toxicity . After completion study treatment , patient follow periodically 2 year . PROJECTED ACCRUAL : A total 20 patient accrue study .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Neoplasms , Germ Cell Embryonal</mesh_term>
	<mesh_term>Teratoma</mesh_term>
	<mesh_term>Testicular Neoplasms</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Bleomycin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Patients must fulfill follow criterion 1 follow diagnosis : Nonseminoma germ cell tumor ( intermediate risk ) Testis retroperitoneal primary Abnormal marker ( alpha fetoprotein [ AFP ] &gt; 1,000 &lt; 10,000 ng/mL , human chorionic gonadotropin [ HCG ] &gt; 5,000 &lt; 50,000 IU/L , lactate dehydrogenase [ LDH ] &gt; 1.5 time &lt; 10 time upper limit normal [ ULN ] ) No liver , bone , brain , nonpulmonary visceral metastasis Histologic confirmation require AFP HCG grossly elevate Nonseminoma germ cell tumor ( poor prognosis ) meeting 1 follow criterion : Mediastinal primary Nonpulmonary visceral metastasis Poor marker ( AFP &gt; 10,000 ng/mL , HCG &gt; 50,000 IU/L , LDH &gt; 10 time ULN ) Histologic confirmation require AFP HCG grossly elevate Seminoma ( intermediate prognosis ) Histological confirmation require Any primary site Nonpulmonary visceral metastasis must present Normal AFP Any HCG Any LDH Surveillance relapse Must fulfill appropriate criterion accord initial histology PATIENT CHARACTERISTICS : Neutrophil count ≥ 1,000/mm³ Platelet count ≥ 100,000/mm³ Must adequate renal function ( creatinine clearance ≥ 60 mL/min ) No prior malignancy except basal cell carcinoma PRIOR CONCURRENT THERAPY : No prior chemotherapy radiotherapy</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>August 2007</verification_date>
	<keyword>stage III malignant testicular germ cell tumor</keyword>
	<keyword>testicular choriocarcinoma seminoma</keyword>
	<keyword>testicular embryonal carcinoma seminoma</keyword>
	<keyword>testicular choriocarcinoma embryonal carcinoma</keyword>
	<keyword>testicular choriocarcinoma teratoma</keyword>
	<keyword>testicular choriocarcinoma</keyword>
	<keyword>testicular choriocarcinoma yolk sac tumor</keyword>
	<keyword>testicular embryonal carcinoma teratoma seminoma</keyword>
	<keyword>testicular embryonal carcinoma teratoma</keyword>
	<keyword>testicular embryonal carcinoma yolk sac tumor seminoma</keyword>
	<keyword>testicular embryonal carcinoma yolk sac tumor</keyword>
	<keyword>testicular embryonal carcinoma</keyword>
	<keyword>testicular seminoma</keyword>
	<keyword>testicular yolk sac tumor</keyword>
	<keyword>testicular yolk sac tumor teratoma seminoma</keyword>
	<keyword>testicular yolk sac tumor teratoma</keyword>
	<keyword>recurrent malignant testicular germ cell tumor</keyword>
	<keyword>recurrent extragonadal non-seminomatous germ cell tumor</keyword>
	<keyword>recurrent extragonadal seminoma</keyword>
	<keyword>stage IV extragonadal non-seminomatous germ cell tumor</keyword>
	<keyword>stage IV extragonadal seminoma</keyword>
	<keyword>adult teratoma</keyword>
	<keyword>testicular immature teratoma</keyword>
	<keyword>testicular mature teratoma</keyword>
	<keyword>recurrent extragonadal germ cell tumor</keyword>
</DOC>